Illumina Inc (NAS:ILMN)
$ 140.6 -4.55 (-3.13%) Market Cap: 22.30 Bil Enterprise Value: 24.77 Bil PE Ratio: 0 PB Ratio: 10.45 GF Score: 79/100

Illumina Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 02:30PM GMT
Release Date Price: $438.06 (+3.86%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everyone. I'm Matt Sykes, life sciences, tools and diagnostics analyst at Goldman Sachs. And I have the pleasure of welcoming Illumina to our conference today. I wanted to introduce Francis deSouza, the Chief Executive Officer of Illumina. Francis, thank you so much for being here with us. We really appreciate it.

Francis A. deSouza
Illumina, Inc. - CEO & Director

Thanks for having me, Matt, and thank you to the entire Goldman community for allowing me to speak to you today.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. And let me just start out with the brief disclaimers that, due to restriction, I cannot ask any questions about GRAIL during this session. But we have plenty of other questions that we can address.

And maybe, Francis, I'll turn it over to you first just to kind of start out and set the stage for us,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot